Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation
暂无分享,去创建一个
N. Laird | G. Washko | E. Silverman | E. Hoffman | F. Martinez | G. Criner | M. Cho | T. Hoffmann | J. Reilly
[1] C M Fletcher,et al. The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. , 1966, Lancet.
[2] V. Baranov,et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis , 1997, Human Genetics.
[3] J. Bousquet,et al. Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis , 1997 .
[4] P. Hiemstra,et al. Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .
[5] P. Hiemstra,et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[6] M. Tsukino,et al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[7] V. Sharma,et al. Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage , 2000 .
[8] M. Suthanthiran,et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] H. Magnussen,et al. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[10] J. Wedzicha. The heterogeneity of chronic obstructive pulmonary disease , 2000, Thorax.
[11] F. Yamasawa,et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). , 2001, American journal of respiratory and critical care medicine.
[12] J. Ioannidis,et al. Replication validity of genetic association studies , 2001, Nature Genetics.
[13] M. Selman,et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. , 2001, The European respiratory journal.
[14] N. Anthonisen,et al. Susceptibility genes for rapid decline of lung function in the lung health study. , 2001, American journal of respiratory and critical care medicine.
[15] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[16] H. Shirasawa,et al. Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. , 2002, Chest.
[17] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[18] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[19] H. Kerstjens. The GOLD classification has not advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.
[20] B. Celli,et al. Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.
[21] D. Ruppert. The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2004 .
[22] Jan Stolk,et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[23] Scott T. Weiss,et al. The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) , 2004 .
[24] S. Muro,et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. , 2004, Chest.
[25] P. Calverley. The GOLD classification has advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.
[26] P. Paré,et al. Glutathione S-transferase variants and their interaction with smoking on lung function. , 2004, American journal of respiratory and critical care medicine.
[27] P. Black,et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. , 2004, Thorax.
[28] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[29] H. Mal,et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. , 2005, Chest.
[30] I. Pavord,et al. Multi‐dimensional phenotyping: towards a new taxonomy for airway disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[31] N. Laird,et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. , 2005, American journal of respiratory cell and molecular biology.
[32] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[33] R. Mitchell. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance , 2006 .
[34] E. Silverman,et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.
[35] B. Celli. Chronic obstructive pulmonary disease phenotypes and their clinical relevance , 2006 .
[36] Christoph Lange,et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. , 2006, American journal of human genetics.
[37] D. DeMeo,et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[38] A. Gulsvik,et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 , 2006, European Respiratory Journal.
[39] E. Silverman. Progress in chronic obstructive pulmonary disease genetics. , 2006, Proceedings of the American Thoracic Society.
[40] B. Celli. Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. , 2006, Proceedings of the American Thoracic Society.
[41] M. Hasegawa,et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease , 2007, Thorax.
[42] D. DeMeo,et al. Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery , 2007, Respiratory research.
[43] B. Make,et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. , 2007, American journal of respiratory and critical care medicine.
[44] Edwin K Silverman,et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. , 2006, American journal of respiratory and critical care medicine.
[45] Edwin K Silverman,et al. Computed Tomography Phenotypes in Severe, Early-Onset Chronic Obstructive Pulmonary Disease , 2007, COPD.
[46] Gianna Camiciottoli,et al. Identification of a predominant COPD phenotype in clinical practice. , 2008, Respiratory medicine.
[47] M. Ota,et al. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. , 2008, Internal medicine.
[48] H. Ortega,et al. Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[49] G. Anderson,et al. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.
[50] Mike Thomas,et al. Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.
[51] Eric A. Hoffman,et al. Computed Tomographic-Based Quantification of Emphysema and Correlation to Pulmonary Function and Mechanics , 2008, COPD.
[52] J. Reilly. COPD and declining FEV1--time to divide and conquer? , 2008, The New England journal of medicine.
[53] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[54] J. Vestbo,et al. The many "small COPDs": COPD should be an orphan disease. , 2008, Chest.
[55] Yasutaka Nakano,et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[56] M. McInnis,et al. Psychiatric genetics: progress amid controversy , 2008, Nature Reviews Genetics.
[57] J. Seo,et al. Quantitative Assessment of Emphysema, Air Trapping, and Airway Thickening on Computed Tomography , 2008, Lung.
[58] E. Silverman,et al. Polymorphic variation in surfactant protein B is associated with COPD exacerbations , 2008, European Respiratory Journal.
[59] S Muro,et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT , 2008, Thorax.
[60] M. Pistolesi. Beyond airflow limitation: another look at COPD , 2008, Thorax.
[61] Dave Singh,et al. COPD phenotype description using principal components analysis , 2009, Respiratory research.
[62] M. Chan-yeung,et al. Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease. , 2009, Respiratory medicine.
[63] Gianna Camiciottoli,et al. Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes , 2009, J. Biomed. Informatics.
[64] M. Weatherall,et al. Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.
[65] Raúl San José Estépar,et al. CT metrics of airway disease and emphysema in severe COPD. , 2009, Chest.
[66] Byron C. Wallace,et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. , 2009, Human molecular genetics.
[67] Edwin K Silverman,et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.